https://www.selleckchem.com/pr....oducts/pembrolizumab
Electronic algorithms identified 260 potential MACE cases 38 confirmed via linkage to hospital records (CPRD GOLD), 56 ruled out as non-cardiovascular death cases (THIN), and three unavailable for review (ISD), leaving 163 potential cases. After manual review with additional information (steps 2 and 3), 45 were considered noncases (CPRD GOLD/THIN). Upon final adjudication (step 4), remaining potential events were adjudicated as definite (n = 62), probable (n = 1, possible (n = 13), or noncases (n = 33). Given the limitations of
Like
Comment
Share
